Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
August's 10 most popular stories: A historic procedure, a massive recall, high salaries & more
Thursday, September 1, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

The Month in Review

Cardiologists make history, becoming first to use FDA-cleared retrieval device to remove a heart tumor

The historic procedure took approximately 30 minutes, and the patient went home that same day. 

READ MORE >
Interventional cardiologists at the University of Washington (UW) have used the new Ōnocor catheter-delivered retrieval device to remove a benign tumor from a patient’s heart. This is the first time such a device has ever been used to remove a heart tumor.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists make history, becoming first to use FDA-cleared retrieval device to remove a heart tumor

Share on Twitter Share on Facebook Share on Linkedin
Interventional cardiologists at the University of Washington (UW) have used the new Ōnocor catheter-delivered retrieval device to remove a benign tumor from a patient’s heart. This is the first time such a device has ever been used to remove a heart tumor.
The historic procedure took approximately 30 minutes, and the patient went home that same day. 
READ MORE >

FDA announces recall of nearly 88,000 implantable cardiac devices due to risk of serious injury or death

The recall is related to short circuit protection (SCP) alerts that were causing the devices to send reduced-energy electric shocks. There have been 27 customer complaints about the issue so far.

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of nearly 88,000 implantable cardiac devices due to risk of serious injury or death

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The recall is related to short circuit protection (SCP) alerts that were causing the devices to send reduced-energy electric shocks. There have been 27 customer complaints about the issue so far.
READ MORE >

Cardiologists earn the highest average salary in all of healthcare

The new report, based on data from the U.S. Bureau of Labor Statistics, once again highlights the fact that cardiology is associated with high demand and high compensation in today's market. 

READ MORE >
Money dollar investments
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists earn the highest average salary in all of healthcare

Share on Twitter Share on Facebook Share on Linkedin
Money dollar investments
The new report, based on data from the U.S. Bureau of Labor Statistics, once again highlights the fact that cardiology is associated with high demand and high compensation in today's market. 
READ MORE >

‘The end of an era’: Influential cardiologist, dead at 88, made a lasting impact

“We are so fortunate to have had fearless luminaries such as Harry Page at the helm of our profession,” SCAI President Sunil V. Rao, MD, said in a statement.

READ MORE >
Harry Lee Page, Jr., MD, a veteran cardiologist who helped pioneer many modern interventional techniques, died on August 11 after a long illness. He was 88 years old. SCAI
Share on Twitter Share on Facebook Share on Linkedin

‘The end of an era’: Influential cardiologist, dead at 88, made a lasting impact

Share on Twitter Share on Facebook Share on Linkedin
Harry Lee Page, Jr., MD, a veteran cardiologist who helped pioneer many modern interventional techniques, died on August 11 after a long illness. He was 88 years old. SCAI
“We are so fortunate to have had fearless luminaries such as Harry Page at the helm of our profession,” SCAI President Sunil V. Rao, MD, said in a statement.
READ MORE >

Common heart medications linked to an increased heart attack risk in hot weather

New research out of the Yale School of Public Health suggests that patients taking beta-blockers or antiplatelet medications may want to be extra careful in warmer weather.

READ MORE >
New research out of the Yale School of Public Health suggests that patients taking beta-blockers or antiplatelet medications may want to be extra careful in warmer weather.
Share on Twitter Share on Facebook Share on Linkedin

Common heart medications linked to an increased heart attack risk in hot weather

Share on Twitter Share on Facebook Share on Linkedin
New research out of the Yale School of Public Health suggests that patients taking beta-blockers or antiplatelet medications may want to be extra careful in warmer weather.
New research out of the Yale School of Public Health suggests that patients taking beta-blockers or antiplatelet medications may want to be extra careful in warmer weather.
READ MORE >

Cardiac CT now in the spotlight thanks to chest pain guidelines

With the elevation of cardiac CT to a 1A indication in the 2021 Chest Pain Guidelines, there has been a large amount of interest in starting coronary artery CT angiography (CCTA) programs. 

READ MORE >
A cardiac CT scan being performed at Duly Healthcare in suburban Chicago in the spring of 2022. This is one of the first outpatient cardiology clinics in the U.S. to implement a CCTA program for screening non-acute chest pain patients and for structural heart evaluations. This applies to CCTA, CTA, Cardiac CT, and CT angiography and coronary CT angiography.
Share on Twitter Share on Facebook Share on Linkedin

Cardiac CT now in the spotlight thanks to chest pain guidelines

Share on Twitter Share on Facebook Share on Linkedin
A cardiac CT scan being performed at Duly Healthcare in suburban Chicago in the spring of 2022. This is one of the first outpatient cardiology clinics in the U.S. to implement a CCTA program for screening non-acute chest pain patients and for structural heart evaluations. This applies to CCTA, CTA, Cardiac CT, and CT angiography and coronary CT angiography.
With the elevation of cardiac CT to a 1A indication in the 2021 Chest Pain Guidelines, there has been a large amount of interest in starting coronary artery CT angiography (CCTA) programs. 
READ MORE >

Possible carcinogen detected in multiple type 2 diabetes medications

To avoid a potential shortage, FDA officials have said the medications can be sold to patients on a temporary basis. 

READ MORE >
Merck Januvia Janumet Steglujan Nitroso-STG-19 (NTTP) type 2 diabetes
Share on Twitter Share on Facebook Share on Linkedin

Possible carcinogen detected in multiple type 2 diabetes medications

Share on Twitter Share on Facebook Share on Linkedin
Merck Januvia Janumet Steglujan Nitroso-STG-19 (NTTP) type 2 diabetes
To avoid a potential shortage, FDA officials have said the medications can be sold to patients on a temporary basis. 
READ MORE >

Cardiologists linked to higher net worths, larger homes and less debt than many other physicians

Twenty-three percent of cardiologists have a net worth of more than $5 million, No. 5 among all specialties, according to a new report. A majority of cardiologists also said they have had no significant financial losses in the last year.

READ MORE >
Twenty-three percent of cardiologists have a net worth of more than $5 million, No. 5 among all specialties, according to a new report. A majority of cardiologists also said they have had no significant financial losses in the last year. What are cardiologists paid? How much do cardiologists make?
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists linked to higher net worths, larger homes and less debt than many other physicians

Share on Twitter Share on Facebook Share on Linkedin
Twenty-three percent of cardiologists have a net worth of more than $5 million, No. 5 among all specialties, according to a new report. A majority of cardiologists also said they have had no significant financial losses in the last year. What are cardiologists paid? How much do cardiologists make?
Twenty-three percent of cardiologists have a net worth of more than $5 million, No. 5 among all specialties, according to a new report. A majority of cardiologists also said they have had no significant financial losses in the last year.
READ MORE >

A new supply issue hits cardiology: 5 recommendations for cardiologists during the dobutamine shortage

The shortage could lead to significant issues for cardiologists. The American College of Cardiology provided some words of wisdom on the ongoing issue.  

READ MORE >
This latest shortage involves dobutamine, an injectable medication often prescribed for advanced heart failure and cardiogenic shock. It is also a central component of dobutamine stress echocardiography (DSE), a test used to evaluate patients with severe aortic stenosis.
Share on Twitter Share on Facebook Share on Linkedin

A new supply issue hits cardiology: 5 recommendations for cardiologists during the dobutamine shortage

Share on Twitter Share on Facebook Share on Linkedin
This latest shortage involves dobutamine, an injectable medication often prescribed for advanced heart failure and cardiogenic shock. It is also a central component of dobutamine stress echocardiography (DSE), a test used to evaluate patients with severe aortic stenosis.
The shortage could lead to significant issues for cardiologists. The American College of Cardiology provided some words of wisdom on the ongoing issue.  
READ MORE >

SAPT after TAVR preferred over DAPT, new meta-analysis confirms

An international team of researchers, led by specialists from Cleveland Clinic, found that DAPT was consistently linked to a greater risk of major or life-threatening bleeding events. 

READ MORE >
doctor.jpg
Share on Twitter Share on Facebook Share on Linkedin

SAPT after TAVR preferred over DAPT, new meta-analysis confirms

Share on Twitter Share on Facebook Share on Linkedin
doctor.jpg
An international team of researchers, led by specialists from Cleveland Clinic, found that DAPT was consistently linked to a greater risk of major or life-threatening bleeding events. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme